Predicting Treatment Response to Cognitive Behavioral Therapy in Panic Disorder With Agoraphobia by Integrating Local Neural Information

Abstract

IMPORTANCE Although neuroimaging research has made substantial progress in identifying the large-scale neural substrate of anxiety disorders, its value for clinical application lags behind expectations. Machine-learning approaches have predictive potential for individual-patient prognostic purposes and might thus aid translational efforts in psychiatric research. OBJECTIVE To predict treatment response to cognitive behavioral therapy (CBT) on an individual-patient level based on functional magnetic resonance imaging data in patients with panic disorder with agoraphobia (PD/AG). DESIGN, SETTING, AND PARTICIPANTS We included 49 patients free of medication for at least 4 weeks and with a primary diagnosis of PD/AG in a longitudinal study performed at 8 clinical research institutes and outpatient centers across Germany. The functional magnetic resonance imaging study was conducted between July 2007 and March 2010. INTERVENTIONS Twelve CBT sessions conducted 2 times a week focusing on behavioral exposure. MAIN OUTCOMES AND MEASURES Treatment response was defined as exceeding a 50% reduction in Hamilton Anxiety Rating Scale scores. Blood oxygenation level-dependent signal was measured during a differential fear-conditioning task. Regional and whole-brain gaussian process classifiers using a nested leave-one-out cross-validation were used to predict the treatment response from data acquired before CBT. RESULTS Although no single brain region was predictive of treatment response, integrating regional classifiers based on data from the acquisition and the extinction phases of the fear-conditioning task for the whole brain yielded good predictive performance (accuracy, 82%; sensitivity, 92%; specificity, 72%; P < .001). Data from the acquisition phase enabled 73% correct individual-patient classifications (sensitivity, 80%; specificity, 67%; P < .001), whereas data from the extinction phase led to an accuracy of 74% (sensitivity, 64%; specificity, 83%; P < .001). Conservative reanalyses under consideration of potential confounders yielded nominally lower but comparable accuracy rates (acquisition phase, 70%; extinction phase, 71%; combined, 79%). CONCLUSIONS AND RELEVANCE Predicting treatment response to CBT based on functional neuroimaging data in PD/AG is possible with high accuracy on an individual-patient level. This novel machine-learning approach brings personalized medicine within reach, directly supporting clinical decisions for the selection of treatment options, thus helping to improve response rates.

Detection of Mild Traumatic Brain Injury by Machine Learning Classification Using Resting State Functional Network Connectivity and Fractional Anisotropy

“…Over-fitting was avoided by using a nested leave-one-out cross validation (LOOCV) to select the appropriate SVM configuration as it has been done before in the literature. 41,42 The sequential minimal optimization (SMO) and least square (LS) methods for solving SVMs were considered. Six different values [0.05, 0.1, 0.5, 1.0, 5.0, 10.0] of SVM's soft margin parameter were also considered.…”

The role of machine learning in neuroimaging for drug discovery and development

“…Using an independent test cohort (N=14), they achieved 85 % accuracy in predicting response to clozapine. Hahn et al (2015) acquired an fMRI paradigm in medication-free patients with panic disorder with agoraphobia after which cognitive behavioural therapy was conducted over several weeks. Gaussian process classification was used to predict response in 46 patients with an accuracy of 79 % on combining predictions from two aspects of the fMRI paradigm.…”

Separating generalized anxiety disorder from major depression using clinical, hormonal, and structural MRI data: A multimodal machine learning study

“…At the moment, the potential biomarkers investigated here would likely be outperformed by standardized clinical interviews in terms of accuracy and cost‐efficiency. Still, biomarkers bear potential for their usage in clinical contexts of mental disorders as, for example first studies provided promising findings for the prediction of treatment outcomes (Hahn et al., 2015; Levine, Rabinowitz, Uher, & Kapur, 2015; Uher, Tansey, Malki, & Perlis, 2012). The sample size was small in this study, groups were unbalanced and GAD subjects had to be separated only from one other related disorder.…”